Voyageur Pharmaceuticals (CVE:VM) Trading 9.1% Higher – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price rose 9.1% during mid-day trading on Friday . The stock traded as high as C$0.12 and last traded at C$0.12. Approximately 835,000 shares traded hands during trading, an increase of 756% from the average session volume of 97,601 shares. The stock had previously closed at C$0.11.

Voyageur Pharmaceuticals Price Performance

The firm’s fifty day moving average price is C$0.10 and its 200 day moving average price is C$0.13. The company has a quick ratio of 0.84, a current ratio of 0.18 and a debt-to-equity ratio of 6.05. The stock has a market cap of C$25.13 million, a PE ratio of -14.00 and a beta of 0.78.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.